For vitiligo, combining phototherapy with topical antioxidants, corticosteroids, or calcineurin inhibitors may offer the best ...
CorestemChemon Inc. (KOSDAQ: 166480) announced today that it has presented key findings from the Phase 3 ALSummit trial of ...
Secondary analysis of Women’s Health Initiative data finds no elevated atherosclerotic cardiovascular risk in hormone therapy ...
Dual vs mono antiviral therapy demonstrated superior mortality reduction among high-risk, hospitalized patients with severe ...
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing based on four Phase 3 studies that met all primary and co-primary endpoints.
Discover a study suggesting shorter antibiotic courses may be as effective as longer durations for cirrhosis-related ...
Subgroup analysis in clinical trials constitutes a vital methodological tool to uncover differential treatment effects within specified categories of patients. This approach enables researchers to ...
New analysis of ZORYVE foam 0.3% demonstrates reduction in signs and symptoms of seborrheic dermatitis in individuals with diverse skin typesNew ...
Neoadjuvant FOLFIRINOX and gemcitabine-based chemoradiotherapy yield similar overall survival in patients with resectable or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback